Assignee profile:

Actogenix NV

City:

Zwijnaarde

Country:

Belgium

Published Applications:

17

Last publication date:

2014-10-30

Patent Grants:

13

Last grant date:

2017-01-10

Top Inventors for applications by Actogenix NV

These are the the leading inventors for applications assigned to Actogenix NV:

Recent patent applications by Actogenix NV

Actogenix NV based in Zwijnaarde, BE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-10-30 ✅ Patent 9,539,291 granted on 2017-01-10
US20140322266A1
Human necessities

Induction of mucosal tolerance to antigens

#2 | 2014-10-30 ✅ Patent 9,526,750 granted on 2016-12-27
US20140322230A1
Human necessities

Induction of mucosal tolerance to antigens

#3 | 2014-04-17 ✅ Patent 9,920,324 granted on 2018-03-20
US20140105863A1
Chemistry; metallurgy

Polycistronic expression system for bacteria

#4 | 2013-12-12 ✅ Patent 10,143,729 granted on 2018-12-04
US20130330374A1
Human necessities

Treatment of immune disease by mucosal delivery of antigens using genetically modified Lactococcus

#5 | 2013-06-27
US20130164380A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS

#6 | 2013-04-18 ✅ Patent 8,524,246 granted on 2013-09-03
US20130095129A1
Human necessities

Treatment of immune disease by mucosal delivery of antigents using genetically modified

#7 | 2012-07-19
US20120183503A1
Chemistry; metallurgy

LACTOBACILLUS AND STREPTOCOCCUS PROMOTERS AND USES THEREOF

#8 | 2012-02-16 ✅ Patent 9,574,169 granted on 2017-02-21
US20120039853A1
Human necessities

Cryoprotectants for freeze drying of lactic acid bacteria

#9 | 2010-12-02
US20100303777A1
Chemistry; metallurgy

DELIVERY OF BINDING MOLECULES TO INDUCE IMMUNOMODULATION

#10 | 2010-07-08 ✅ Patent 8,398,995 granted on 2013-03-19
US20100172920A1
Human necessities

Method of inducing immune tolerance to type I diabetes

#11 | 2010-04-01 ✅ Patent 8,759,088 granted on 2014-06-24
US20100080774A1
Chemistry; metallurgy

Lactococcus promoters and uses thereof

#12 | 2009-06-11 ✅ Patent 8,748,126 granted on 2014-06-10
US20090148389A1
Human necessities

Induction of mucosal tolerance to antigens

#13 | 2009-03-19
US20090074734A1
Chemistry; metallurgy

MICROBIAL INTESTINAL DELIVERY OF OBESITY RELATED PEPTIDES

#14 | 2008-11-06 ✅ Patent 9,017,662 granted on 2015-04-28
US20080274084A1
Chemistry; metallurgy

Anti-TNF alpha producing lactic acid bacteria for the treatment of chronic enterocolitis

#15 | 2007-11-08 ✅ Patent 9,200,249 granted on 2015-12-01
US20070258965A1
Chemistry; metallurgy

Method to improve preservation

#16 | 2005-07-21 ✅ Patent 7,601,799 granted on 2009-10-13
US20050158282A1
Chemistry; metallurgy

Methods and means to promote gut absorption

#17 | 2005-05-12 ✅ Patent 7,780,961 granted on 2010-08-24
US20050101005A1
Chemistry; metallurgy

Self-containing strain

Also check out Actogenix NV's (Zwijnaarde, Belgium) applicant profile with 1 patent applications submitted.

AssigneeID:

18445 ⎘